Dr Andrew Rut, CEO and founder of MyMeds&Me, examines the critical role of new technology, in the form of smart pharmaceuticals and blockchain, in advancing patient autonomy and drug development.
digital pill
The advent of smart pharmaceuticals has substantially changed the way in which the pharmaceutical industry interacts with its patients. It is now possible to collect purer data faster, facilitating patients’ autonomy over their own health, and making the research and development (R&D) process more efficient for drug developers.